Viewing Study NCT02877303


Ignite Creation Date: 2025-12-24 @ 7:13 PM
Ignite Modification Date: 2026-02-21 @ 4:11 AM
Study NCT ID: NCT02877303
Status: RECRUITING
Last Update Posted: 2025-11-06
First Post: 2016-08-19
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Blinatumomab, Inotuzumab Ozogamicin, and Combination Chemotherapy as Frontline Therapy in Treating Patients With B Acute Lymphoblastic Leukemia
Sponsor: M.D. Anderson Cancer Center
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module